Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Silibinin component for the treatment of hepatitis

Silibinin component for the treatment of hepatitis

US Patent 9248115 · Granted Feb 2, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

FYN and VEGFR2 kinase inhibitors2025
(R)-4-(1-(6-(4-(trifluoromethyl)benzyl)-6-azaspiro[2.5]octane-5-carboxamido)-cyc2025
Process for the preparation of (R)-4-(1-(6-(4-(trifluoromethyl)benzyl)-6-azaspir2025
Bis-choline tetrathiomolybdate for treating Wilson Disease2025
(R)-4-(1-(1-(4-(trifluoromethyl)benzyl)pyrrolidine-2-carboxamide)cyclopropyl)-be2023
Pharmaceutical combination of an EP4 antagonist and immune checkpoint inhibitors2023
Bis-choline tetrathiomolybdate for treating Wilson disease2022
Bis-choline tetrathiomolybdate for treating Wilson Disease2022
FYN kinase inhibitors2018
Anti-ADAMTS-5 antibody, derivatives and uses thereof2017
Spiro aminic compounds with NK1 antagonist activity2016
Anti-TrkA antibodies, derivatives and uses thereof2016